Abstract
The disclosure relates to combination therapy comprising an inducible cytokine prodrug and an adoptive cell therapy. The disclosure also relates to methods for treating subjects using such combinations.
Full Text
What is claimed is:
The disclosure relates to combination therapy comprising an inducible cytokine prodrug and an adoptive cell therapy. The disclosure also relates to methods for treating subjects using such combinations.
Timeline
Filed
03/26/2026Published
07/16/2026Granted
Not AvailableIPC Codes(15)
A61K 38/20:Interleukins
A61K 31/166:having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 31/197:the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K 31/205)